The Effectiveness, Safety, Adverse Drug Reactions, and Interchangeability of Biopharmaceuticals as Experienced by Public Hospital Doctors from Various Specialties: a Qualitative Study
Received Date: Nov 01, 2022 / Published Date: Nov 30, 2022
Abstract
Although there's increasing support for biosimilar medicines by the Iraqi Ministry of Health (MOH), there's scarce info concerning whether or not physicians settle for these medicines and support movement toward commutation reference medicines with their biosimilar counterparts. The study objectives were to explore in-depth the perceptions of Iraqi physicians operating publically hospitals concerning the distinction in effectiveness and safety between biosimilar medicines and their reference biological counterparts, assess physicians' barriers to prescribing biosimilar medicines, assess the adherence of physicians to the new pharmacovigilance rules on news biopharmaceutical adverse drug reactions (ADRs) and establish any barriers facing physicians to news biopharmaceutical ADRs.his qualitative study enclosed face-to-face and virtual semi-structured interviews involving physicians from completely different disciplines UN agency had expertise with biological or biosimilar medicines.
Citation: Abreu M (2022) The Effectiveness, Safety, Adverse Drug Reactions, and Interchangeability of Biopharmaceuticals as Experienced by Public Hospital Doctors from Various Specialties: a Qualitative Study. Clin Pharmacol Biopharm, 11: 297. Doi: 10.4172/2167-065X.1000297
Copyright: © 2022 Abreu M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 1326
- [From(publication date): 0-2022 - Nov 25, 2024]
- Breakdown by view type
- HTML page views: 1149
- PDF downloads: 177
